Related Experiment Video
Updated: May 9, 2026

T-maze Forced Alternation and Left-right Discrimination Tasks for Assessing Working and Reference Memory in Mice
Published on: February 26, 2012
Two-decade trends in prenatal genetic testing in Japan
Aiko Sasaki1, Takahiro Yamada2, Haruhiko Sago1,3
1Center for Maternal-Fetal, Neonatal and Reproductive Medicine/Center for Medical Genetics, National Center for Child Health and Development, Tokyo, Japan.
Prenatal genetic testing in Japan shows declining use of traditional methods like maternal serum screening and amniocentesis, alongside a rise in ultrasound-only screening. This shift is influenced by non-invasive prenatal testing (NIPT) and evolving reproductive choices.
Area of Science:
- Reproductive Medicine and Genetics
- Clinical Diagnostics and Laboratory Medicine
Background:
- Prenatal genetic testing in Japan has evolved significantly over two decades.
- Maternal serum screening (MSS), amniocentesis (AC), and chorionic villus sampling (CVS) were primary methods for detecting fetal chromosomal abnormalities.
- Non-invasive prenatal testing (NIPT) has recently emerged as a transformative tool in clinical decision-making.
Purpose of the Study:
- To assess the current landscape and trends of prenatal genetic testing in Japan.
- To update national data on conventional prenatal testing methods amidst the rise of NIPT.
- To analyze the impact of demographic changes and new testing technologies on prenatal screening practices.
Main Methods:
- Compiled test volume data from five major high-volume laboratories analyzing prenatal genetic tests (2020-2023).
- Conducted a supplemental nationwide questionnaire-based survey on ultrasound (US)-only screening.
- Analyzed trends in MSS, AC, CVS, and US-only screening volumes and detection rates.
Main Results:
- Significant decline observed in MSS (34,887 in 2018 to 25,553 in 2023), AC (16,454 in 2014 to 5620 in 2023), and CVS (2149 in 2015 to 1167 in 2023) volumes.
- Ultrasound-only screening showed a slight increase, exceeding 10,000 cases annually.
- Chromosomal abnormality detection rate in AC cases increased to 20.0% in 2023, with trisomy 21 being most common (43.6%).
- Proportion of mothers aged ≥35 years increased (14.0% in 2003 to 30.4% in 2023), while national live births decreased by 35.3%.
Conclusions:
- Declining conventional prenatal test volumes are influenced by NIPT adoption, improved risk stratification, and evolving reproductive decisions.
- Demographic shifts alone do not explain the observed decrease in traditional testing methods.
- This study provides essential data for future prenatal genetic testing policies and practices in Japan.
Related Concept Videos
Animal Mitochondrial Genetics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Meiosis I
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...

